Cargando…

Tocilizumab for severe COVID-19: a systematic review and meta-analysis

This systemic review and meta-analysis aimed to assess the efficacy of tocilizumab for the treatment of severe coronavirus disease 2019 (COVID-19). Candidate studies up to 24 May 2020 were identified from PubMed, Cochrane Library, Embase, medRxiv and bioRxiv. Treatment outcomes included mortality, r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lan, Shao-Huan, Lai, Chih-Cheng, Huang, Hui-Ting, Chang, Shen-Peng, Lu, Li-Chin, Hsueh, Po-Ren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. and International Society of Chemotherapy. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377685/ https://www.ncbi.nlm.nih.gov/pubmed/32712333 http://dx.doi.org/10.1016/j.ijantimicag.2020.106103

Ejemplares similares

Efficacy and safety of delafloxacin in the treatment of acute bacterial skin and skin structure infections: a systematic review and meta-analysis of randomized controlled trials
por: Lan, Shao-Huan, et al.
Publicado: (2019)

Accelerated-strategy renal replacement therapy for critically ill patients: A systematic review and meta-analysis
por: Lan, Shao-Huan, et al.
Publicado: (2022)

Effect of fluvoxamine on outcomes of nonhospitalized patients with COVID-19: A systematic review and meta-analysis
por: Lu, Li-Chin, et al.
Publicado: (2022)

Vitamin D supplementation and the outcomes of critically ill adult patients: a systematic review and meta-analysis of randomized controlled trials
por: Lan, Shao-Huan, et al.
Publicado: (2020)

Clinical efficacy and safety of interleukin-1 blockade in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials
por: Lan, Shao-Huan, et al.
Publicado: (2023)

Effect of colchicine on the outcomes of patients with COVID-19: a systematic review and meta-analysis of randomised controlled trials
por: Lan, Shao-Huan, et al.
Publicado: (2022)

Tedizolid Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection: A Systematic Review and Meta-Analysis
por: Lan, Shao-Huan, et al.
Publicado: (2019)

Efficacy and safety of cefoperazone-sulbactam in empiric therapy for febrile neutropenia: A systemic review and meta-analysis
por: Lan, Shao-Huan, et al.
Publicado: (2020)

Efficacy and Safety of Ceftaroline for the Treatment of Community-Acquired Pneumonia: A Systemic Review and Meta-Analysis of Randomized Controlled Trials
por: Lan, Shao-Huan, et al.
Publicado: (2019)

The efficacy and safety of omadacycline in treatment of acute bacterial infection: A systemic review and meta-analysis of randomized controlled trials
por: Lan, Shao-Huan, et al.
Publicado: (2019)

The Efficacy and Safety of Eravacycline in the Treatment of Complicated Intra-Abdominal Infections: A Systemic Review and Meta-Analysis of Randomized Controlled Trials
por: Lan, Shao-Huan, et al.
Publicado: (2019)

Ceftaroline Efficacy and Safety in Treatment of Complicated Skin and Soft Tissue Infection: A Systemic Review and Meta-Analysis of Randomized Controlled Trials
por: Lan, Shao-Huan, et al.
Publicado: (2019)

Novel β-Lactam/β-Lactamase inhibitor combinations vs alternative antibiotics in the treatment of complicated urinary tract infections: A meta-analysis of randomized controlled trials
por: Lu, Li-Chin, et al.
Publicado: (2020)

The effect of tocilizumab on COVID-19 patient mortality: A systematic review and meta-analysis of randomized controlled trials
por: Lin, Wei-Ting, et al.
Publicado: (2021)

Novel Tetracyclines Versus Alternative Antibiotics for Treating Acute Bacterial Infection: A Meta-Analysis of Randomized Controlled Trials
por: Lan, Shao-Huan, et al.
Publicado: (2019)

Risk of Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Undergoing Tocilizumab-Containing Treatment
por: Kuo, Meng Hsuan, et al.
Publicado: (2021)

Clinical efficacy of antiviral agents against coronavirus disease 2019: A systematic review of randomized controlled trials
por: Lai, Chih-Cheng, et al.
Publicado: (2021)

Optimal use of tocilizumab for severe and critical COVID-19: a systematic review and meta-analysis
por: Nugroho, Cahyo Wibisono, et al.
Publicado: (2021)

Tocilizumab in severe COVID-19
por: Lucio Liberato, Nicola, et al.
Publicado: (2020)

Association between tocilizumab treatment and clinical outcomes of COVID-19 patients: a systematic review and meta-analysis
por: Peng, Jingwen, et al.
Publicado: (2022)

Beyond mental stress-induced myocardial ischemia following the COVID-19 vaccine
por: Lai, Chih-Cheng, et al.
Publicado: (2023)

Efficacy and safety of adjunctive corticosteroids in the treatment of severe community-acquired pneumonia: a systematic review and meta-analysis of randomized controlled trials
por: Wu, Jheng-Yan, et al.
Publicado: (2023)

The effect of zinc on the outcome of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials
por: Wu, Jheng-Yan, et al.
Publicado: (2023)

Efficacy and secondary infection risk of tocilizumab, sarilumab and anakinra in COVID‐19 patients: A systematic review and meta‐analysis
por: Peng, Jingwen, et al.
Publicado: (2021)

Effectiveness of intergenerational participation on residents with dementia: A systematic review and meta‐analysis
por: Lu, Li‐Chin, et al.
Publicado: (2021)

Genetic Biomarkers as Predictors of Response to Tocilizumab in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
por: Janahiraman, Sivakami, et al.
Publicado: (2022)

Addition of Tocilizumab to the Standard of Care Reduces Mortality in Severe COVID-19: A Systematic Review and Meta-Analysis
por: Boregowda, Umesha, et al.
Publicado: (2020)

Correction to: Efficacy and safety of adjunctive corticosteroids in the treatment of severe community‑acquired pneumonia: a systematic review and meta‑analysis of randomized controlled trials
por: Wu, Jheng‑Yan, et al.
Publicado: (2023)

Tocilizumab for severe COVID-19 pneumonia
por: Mourad, Jean-Jacques, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Lipworth, Brian J, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Piano, Salvatore, et al.
Publicado: (2020)

Efficacy and safety of tocilizumab in hospitalized COVID-19 patients: A systematic review and meta-analysis
por: Luo, Lili, et al.
Publicado: (2022)

Efficacy of the early treatment with tocilizumab-hydroxychloroquine and tocilizumab-remdesivir in severe COVID-19 Patients
por: Sarhan, Rania M., et al.
Publicado: (2022)

Cardiovascular safety of tocilizumab: A systematic review and network meta-analysis
por: Castagné, Benjamin, et al.
Publicado: (2019)

Tocilizumab as treatment for COVID-19: A systematic review and meta-analysis
por: Petrelli, Fausto, et al.
Publicado: (2021)

The efficacy and safety of ceftaroline in the treatment of acute bacterial infection in pediatric patients – a systemic review and meta-analysis of randomized controlled trials
por: Chen, Chih-Wei, et al.
Publicado: (2019)

Effects of early dialysis on the outcomes of critically ill patients with acute kidney injury: a systematic review and meta-analysis of randomized controlled trials
por: Lin, Wei-Ting, et al.
Publicado: (2019)

Global coronavirus disease 2019: What has daily cumulative index taught us?
por: Lai, Chih-Cheng, et al.
Publicado: (2020)

Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths
por: Lai, Chih-Cheng, et al.
Publicado: (2020)

Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?
por: Lai, Chih-Cheng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_paut02svdjo22i2splbguts67j